Health
Scientists identify key molecules that mediate radioresistance in aggressive brain cancer – News-Medical.Net
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of th…
Reviewed by Emily Henderson, B.Sc.Sep 30 2020
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of this brain cancer.
Glioblastoma multiforme (GBM), is the most aggressive type of brain cancer. It is treated by radiation therapy combined with chemotherapy. However, even with treatment, the five-year survival rate for GBM is less than 7%. One of the major causes for this is that GBM rapidly …
-
General22 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
Business23 hours agoWhy this fantastic blue chip ASX 200 share could rise 20%
-
General16 hours agoPhotographers reveal iconic image of Gough Whitlam and Vincent Lingiari was posed on Wave Hill Walk-Off anniversary
-
General21 hours agoAustralia beats Samoa 73-0 at Women’s Rugby World Cup